Data / Form D filings / Rapalogix Health, Inc.
Rapalogix Health, Inc.: Form D filings
Rapalogix Health, Inc., a biotechnology company in Carlsbad, CA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on June 26, 2026, reports $19.1 million sold of a $25 million offering to 28 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3129 TIGER RUN COURT SUITE 207, Carlsbad, CA, 92010
- Phone
- (760) 707-2412
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008372
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | New notice | $24,999,999 | $19,112,746 | $5,887,253 | 28 | Jun 22, 2026 | sec.gov |
| Jun 4, 2025 | Amendment | $13,500,000 | $9,079,616 | $4,420,384 | 24 | Dec 22, 2023 | sec.gov |
| Jan 17, 2024 | New notice | $8,000,000 | $8,000,000 | 0 | Dec 22, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rahul Mehta | Executive Officer | |
| James Peyer | Director | |
| Juliette Han | Director | |
| Neetu Dhaliwal | Director | |
| Brent Saunders | Director | |
| Doris Day | Director | |
| David Nicholson | Director | |
| Craig Gordon | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rapalogix Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.